ClinicalTrials.gov record
Completed Phase 3 Interventional

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

ClinicalTrials.gov ID: NCT05614063

Public ClinicalTrials.gov record NCT05614063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Study identification

NCT ID
NCT05614063
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Xenon Pharmaceuticals Inc.
Industry
Enrollment
380 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • XEN1101 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2022
Primary completion
Jan 11, 2026
Completion
Feb 2, 2026
Last update posted
May 13, 2026

2022 – 2026

United States locations

U.S. sites
56
U.S. states
28
U.S. cities
50
Facility City State ZIP Site status
Strada Patient Care Center Mobile Alabama 36604
Xenoscience Phoenix Arizona 85004
University of Arizona, Health Sciences Center Tucson Arizona 85724
Clinical Trials, Inc Little Rock Arkansas 72205
Brain Science Research Institute Los Angeles California 90025
University of California, David Clinical & Translational Science Center Clinical Research (CCRC) Sacramento California 95817
Anschutz Health Sciences Aurora Colorado 80011
Serenity Research Miami Florida 33176
Research Institute of Orlando, LLC Orlando Florida 32806
Panhandle Research & Medical Clinic Pensacola Florida 32503
Medsol Clinical Research Center Port Charlotte Florida 33952
University of South Florida Tampa Florida 33606
Encore Medical Research of Weston, LLC Weston Florida 33021
Emory Brain Health Center Atlanta Georgia 30329
Hawaii Pacific Neuroscience Honolulu Hawaii 96817
Consultants in Epilepsy and Neurology Boise Idaho 83702
Indiana University, IU Health Partners, Adult Neurology Clinic Indianapolis Indiana 46202
The University of Kansas Medical Center Kansas City Kansas 66160
Bluegrass Epilepsy Research, LLC Lexington Kentucky 40504
University of Kentucky, Dept. of Neurology Lexington Kentucky 40536-0284
MaineHealth Neurology - Scarborough Scarborough Maine 04074
University of Maryland Medical Center Baltimore Maryland 21201
Medstar Franklin Square Medical Center Baltimore Maryland 21237
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817
MedStar Georgetown University Hospital Clinton Maryland 20735
Brigham and Women's Hospital Boston Massachusetts 02115
UMass Memorial Medical Center Worcester Massachusetts 01655
University of Michigan Ann Arbor Michigan 48109
Michigan State University East Lansing Michigan 48824
Cornwell Health Grand Rapids Michigan 49506
Minneapolis Clinic of Neurology Burnsville Minnesota 55337
Saint Louis University Medical School - Neurosciences Clinical Research Unit St Louis Missouri 63104
Washington University, St. Louis St Louis Missouri 63110
Northeast Epilepsy Group Hackensack New Jersey 07601
Dent Neurosciences Research Center Buffalo New York 14226
NYU Comprehensive Epilepsy Center (CEC) New York New York 10016
Weill Cornell Medicine/ New York-Presbyterian Hospital New York New York 10021
Mount Sinai Medical Center New York New York 10029
SUNY Upstate Medical University Syracuse New York 13210
Montefiore Medical Center The Bronx New York 10467-2401
Onsite Clinical Solutions, LLC Charlotte North Carolina 28211
Duke Neurology Durham North Carolina 27713
Meridian Clinical Research, LLC Raleigh North Carolina 27607
Wake Forest Baptist Health Winston-Salem North Carolina 27157
Summa Health Akron Ohio 44304
Providence Brain & Spine Institute Portland Oregon 97225
Thomas Jefferson University Philadelphia Pennsylvania 19107
Temple University Hospital Philadelphia Pennsylvania 19140-4105
Austin Epilepsy Care Center (AECC) Austin Texas 78758
ANESC Research El Paso Texas 79912
UT Physicians Epilepsy Clinic Houston Texas 77030
UT Health San Antonio San Antonio Texas 78229
Carilion Clinic - Neurology Roanoke Virginia 24013
Sentara Neurology Specialists Virginia Beach Virginia 23456
University of Washington Main Hospital Seattle Washington 98104
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05614063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05614063 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →